SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-091875
Filing Date
2024-04-10
Accepted
2024-04-10 16:06:10
Documents
15
Period of Report
2024-04-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d824232d8k.htm   iXBRL 8-K 48571
2 EX-10.1 d824232dex101.htm EX-10.1 173142
  Complete submission text file 0001193125-24-091875.txt   430829

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20240409.xsd EX-101.SCH 3878
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20240409_def.xml EX-101.DEF 14074
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20240409_lab.xml EX-101.LAB 23354
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20240409_pre.xml EX-101.PRE 15107
18 EXTRACTED XBRL INSTANCE DOCUMENT d824232d8k_htm.xml XML 5927
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 24835800
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)